Clinical Trials Details

E4512 ALCHEMIST - SUBSTUDY (Lung)

A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib vs. Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Clinical Trial Categories

  • Cancers and Other Neoplasms